Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

A description of the content follows : Spongetech (SPNG) announced they've authorized a repurchase of up to 25 million of the free-trading shares. That's 18.7% of the stock actually in circulation. As far as buybacks go, that's pretty substantial. Applied DNA (APDN) did $252K in business. It's not a ton of money, but considering they did $122K in sales just three quarters earlier. I think it's exciting they managed to more than double their quarterly revenue rate in less than a year.